Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Liver transplantation1521 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A12623 | 30360608 | Asian Pac J Cancer Prev | Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation | 2018 | Details |
| A12633 | 30358115 | Liver Transpl | Overproduction of Tenascin-C Driven by Lipid Accumulation in the Liver Aggravates Hepatic Ischemia/Reperfusion Injury in Steatotic Mice. | 2019 | Details |
| A12644 | 30353054 | Am J Gastroenterol | Non-Alcoholic Steatohepatitis as a Growing Indication for Liver Transplantation: The Evolving Gender and Ethnic Trends. | 2018 | Details |
| A12670 | 30335699 | Transplantation | NAFLD and Liver Transplantation in Children-Working Group Report From the ILTS Single Topic Conference on NAFLD. | 2019 | Details |
| A12671 | 30335697 | Transplantation | Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation. | 2019 | Details |
| A12672 | 30335694 | Transplantation | Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation. | 2019 | Details |
| A12706 | 30320609 | Eur J Gastroenterol Hepatol | High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation. | 2019 | Details |
| A12751 | 30303340 | Minerva Gastroenterol Dietol | Challenges and future developments in liver transplantation. | 2018 | Details |
| A12755 | 30300289 | Transplantation | Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis. | 2019 | Details |
| A12756 | 30300287 | Transplantation | Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH. | 2019 | Details |
| A12808 | 30274326 | Diseases | When to Initiate Weight Loss Medications in the NAFLD Population. | 2018 | Details |
| A12824 | 30266282 | J Hepatol | Burden of liver diseases in the world. | 2018 | Details |
| A12853 | 30257063 | Liver Transpl | Differing Impact of Sarcopenia and Frailty in Nonalcoholic Steatohepatitis and Alcoholic Liver Disease. | 2019 | Details |
| A12927 | 30222962 | Gastroenterology | Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis. | 2018 | Details |
| A12933 | 30219279 | J Control Release | Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis. | 2018 | Details |
| A13007 | 30183584 | Chirurgia (Bucur) | The Role of Beta-7 Integrin and Carbonic Anhydrase IX in Predicting the Occurrence of de Novo Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients. | 2019 | Details |
| A13016 | 30180152 | J Clin Gastroenterol | Pretransplant Sarcopenia in Patients With NASH Cirrhosis Does Not Impact Rehospitalization or Mortality. | 2019 | Details |
| A13070 | 30153225 | Transplantation | International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation. | 2019 | Details |
| A13132 | 30122876 | World J Gastroenterol | Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. | 2018 | Details |
| A13133 | 30122874 | World J Gastroenterol | Nutritional issues in patients with obesity and cirrhosis. | 2018 | Details |
| A13151 | 30113367 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies. | 2018 | Details |
| A13195 | 30091296 | Liver Transpl | Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis. | 2019 | Details |
| A13204 | 30086613 | Clin Mol Hepatol | Recent research trends and updates on nonalcoholic fatty liver disease. | 2018 | Details |
| A13212 | 30080949 | Liver Transpl | Liver Transplantation and Bariatric Surgery: Timing and Outcomes. | 2018 | Details |
| A13224 | 30075518 | Medicine (Baltimore) | Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016. | 2018 | Details |
| A13236 | 30070714 | Hepatology | Patient-Reported Outcomes and the Economic Effects of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: The Value Proposition. | 2018 | Details |
| A13246 | 30065915 | Can J Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease Cirrhosis: A Review of Its Epidemiology, Risk Factors, Clinical Presentation, Diagnosis, Management, and Prognosis. | 2018 | Details |
| A13310 | 30037134 | Int J Mol Sci | High-Content Screening of a Taiwanese Indigenous Plant Extract Library Identifies Syzygium simile leaf Extract as an Inhibitor of Fatty Acid Uptake. | 2018 | Details |
| A13402 | 29994981 | Transplantation | Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation. | 2019 | Details |
| A13419 | 29988867 | World J Transplant | Perioperative glucose management and outcomes in liver transplant recipients: A qualitative systematic review. | 2018 | Details |
| A13422 | 29985186 | Transplantation | Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis. | 2019 | Details |
| A13448 | 29969718 | Free Radic Biol Med | IRE1α aggravates ischemia reperfusion injury of fatty liver by regulating phenotypic transformation of kupffer cells. | 2018 | Details |
| A13457 | 29963467 | Euroasian J Hepatogastroenterol | Nonalcoholic Fatty Liver Disease: Identifying the Disease Burden in Sri Lanka. | 2018 | Details |
| A13458 | 29963463 | Euroasian J Hepatogastroenterol | Hepatocellular Carcinoma in Malaysia and Its Changing Trend. | 2018 | Details |
| A13470 | 29956213 | Adv Exp Med Biol | Current Prevention and Treatment Options for NAFLD. | 2018 | Details |
| A13480 | 29956203 | Adv Exp Med Biol | Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC. | 2018 | Details |
| A13563 | 29908364 | Clin Gastroenterol Hepatol | Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates. | 2018 | Details |
| A13585 | 29894414 | Transplantation | Risk Factors and Clinical Course for Liver Steatosis or Nonalcoholic Steatohepatitis After Living Donor Liver Transplantation. | 2019 | Details |
| A13603 | 29883530 | Transpl Int | Fat and liver transplantation: clinical implications. | 2018 | Details |
| A13608 | 29880964 | Am J Gastroenterol | NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances. | 2018 | Details |
| A13630 | 29863454 | Exp Clin Transplant | Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications. | 2018 | Details |
| A13634 | 29860977 | Adv Food Nutr Res | Omega-3 Fatty Acids and Fatty Liver Disease in Children. | 2018 | Details |
| A13642 | 29858854 | Hormones (Athens) | Imaging of nonalcoholic fatty liver disease and its clinical utility. | 2018 | Details |
| A13646 | 29858436 | Clin Med (Lond) | Non-alcoholic fatty liver disease. | 2018 | Details |
| A13661 | 29851153 | J Gastroenterol Hepatol | Burden of non-alcoholic fatty liver disease in Australia. | 2018 | Details |
| A13681 | 29843693 | BMC Surg | First right lobe living-donor hepatectomy after sleeve gastrectomy. | 2018 | Details |
| A13684 | 29808546 | J Dig Dis | Chronic liver injury induced by drugs and toxins. | 2018 | Details |
| A13691 | 29804305 | Clin Transplant | Gender disparities in liver transplant candidates with nonalcoholic steatohepatitis. | 2018 | Details |
| A13755 | 29773419 | Clin Res Hepatol Gastroenterol | A changing etiologic scenario in liver transplantation for hepatocellular carcinoma in a multicenter cohort study from Latin America. | 2018 | Details |
| A13794 | 29751874 | Surg Pathol Clin | Nonalcoholic Steatohepatitis: Histopathology Basics Within a Broader Context. | 2018 | Details |
| A13834 | 29735782 | Ann Hepatol | An Overview of Liver Transplant Pathology: Data from a Tertiary Referral Centre in Western India. | 2018 | Details |
| A13838 | 29733831 | Gastroenterology | Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study. | 2018 | Details |
| A13847 | 29729104 | Liver Transpl | The impact of diet-induced hepatic steatosis in a murine model of hepatic ischemia/reperfusion injury. | 2018 | Details |
| A13864 | 29720854 | Ann Gastroenterol | Non-alcoholic fatty liver disease: controlling an emerging epidemic, challenges, and future directions. | 2018 | Details |
| A13887 | 29709248 | Transplant Rev (Orlando) | Identifying risk profiles in liver transplant candidates and implications for induction immunosuppression. | 2018 | Details |
| A13916 | 29696060 | J Med Life | Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications. | 2018 | Details |
| A13974 | 29662288 | World J Gastroenterol | Nonalcoholic fatty liver disease and liver transplantation - Where do we stand? | 2018 | Details |
| A13978 | 29661431 | Transplant Proc | Stratifying Mortality in a Model for End-Stage Liver Disease Waiting List: A Brazilian Single-Center Study. | 2018 | Details |
| A13990 | 29655574 | Rev Gastroenterol Mex (Engl Ed) | Current treatment for non-alcoholic fatty liver disease. | 2018 | Details |
| A14006 | 29641680 | Rev Assoc Med Bras (1992) | Nonalcoholic steatohepatitis in posttransplantation liver: Review article. | 2018 | Details |
| A14009 | 29636553 | Hypertens Res | The role of the angiotensin II type I receptor blocker telmisartan in the treatment of non-alcoholic fatty liver disease: a brief review. | 2018 | Details |
| A14014 | 29633440 | Hepatol Res | Augmenter of liver regeneration: A key protein in liver regeneration and pathophysiology. | 2018 | Details |
| A14018 | 29631866 | Gastroenterol Hepatol | Consensus document. Management of non-alcoholic fatty liver disease (NAFLD). Clinical practice guideline. | 2018 | Details |
| A14023 | 29630771 | Liver Int | Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries. | 2018 | Details |
| A14033 | 29624631 | Cancer | Temporal trends in disease presentation and survival of patients with hepatocellular carcinoma: A real-world experience from 1998 to 2015. | 2018 | Details |
| A14051 | 29609450 | Ann Pediatr Endocrinol Metab | Hepatopulmonary syndrome caused by hypothalamic obesity and nonalcoholic fatty liver disease after surgery for craniopharyngioma: a case report. | 2018 | Details |
| A14114 | 29575516 | Liver Int | Diabetes impacts prediction of cirrhosis and prognosis by non-invasive fibrosis models in non-alcoholic fatty liver disease. | 2018 | Details |
| A14157 | 29560688 | Acta Gastroenterol Belg | Prevalence of fat-soluble vitamin (A, D, and E) and zinc deficiency in patients with cirrhosis being assessed for liver transplantation. | 2018 | Details |
| A14223 | 29517271 | Biomark Med | The search for noninvasive methods to identify liver fibrosis in children with nonalcoholic fatty liver disease. | 2018 | Details |
| A14252 | 29505475 | Eur J Gastroenterol Hepatol | De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients. | 2018 | Details |
| A14262 | 29497497 | F1000Res | The role of NAFLD in cardiometabolic disease: an update. | 2018 | Details |
| A14311 | 29470354 | Transplantation | Poor Survival After Retransplantation in NASH Cirrhosis. | 2019 | Details |
| A14325 | 29464180 | Int J Genomics | Lingguizhugan Decoction Protects against High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease by Alleviating Oxidative Stress and Activating Cholesterol Secretion. | 2017 | Details |
| A14381 | 29435319 | United European Gastroenterol J | Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis. | 2017 | Details |
| A14475 | 29396131 | Dig Liver Dis | Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study. | 2018 | Details |
| A14488 | 29386216 | BMJ Case Rep | High-dose steroids as a therapeutic option in the management of spur cell haemolytic anaemia. | 2018 | Details |
| A14521 | 29369303 | AIDS Rev | Report from the International Conference on Viral Hepatitis - 2017. | 2018 | Details |
| A14549 | 29359341 | Aliment Pharmacol Ther | Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients. | 2018 | Details |
| A14555 | 29356708 | Curr Opin Organ Transplant | Nonalcoholic steatohepatitis: the new frontier for liver transplantation. | 2018 | Details |
| A14556 | 29356032 | Hepatology | Noninvasive, Quantitative Assessment of Liver Fat by MRI-PDFF as an Endpoint in NASH Trials. | 2018 | Details |
| A14602 | 29328556 | Liver Transpl | Coronary artery disease in decompensated patients undergoing liver transplantation evaluation. | 2018 | Details |
| A14612 | 29324588 | Eur J Gastroenterol Hepatol | Both α-1-antitrypsin Z phenotypes and low caeruloplasmin levels are over-represented in alcohol and nonalcoholic fatty liver disease cirrhotic patients undergoing liver transplant in Ireland. | 2018 | Details |
| A14621 | 29319620 | Transplantation | Liver Transplantation for NASH-Related Hepatocellular Carcinoma Versus Non-NASH Etiologies of Hepatocellular Carcinoma. | 2018 | Details |
| A14629 | 29316191 | Liver Transpl | Microbiota and the liver. | 2018 | Details |
| A14653 | 29307986 | World J Gastroenterol | Clinical epidemiology and disease burden of nonalcoholic fatty liver disease. | 2017 | Details |
| A14672 | 29292603 | Am J Transplant | OPTN/SRTR 2016 Annual Data Report: Liver. | 2018 | Details |
| A14673 | 29291781 | Hepatobiliary Pancreat Dis Int | Grade of donor liver microvesicular steatosis does not affect the postoperative outcome after liver transplantation. | 2017 | Details |
| A14675 | 29291167 | World J Clin Oncol | Epidemic of non-alcoholic fatty liver disease and hepatocellular carcinoma. | 2017 | Details |
| A14702 | 29281049 | Alcohol Alcohol | The Influence of Alcohol Use on Outcomes in Patients Transplanted for Non-alcoholic Liver Disease. | 2018 | Details |
| A14718 | 29273476 | J Hepatol | Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice. | 2017 | Details |
| A14719 | 29272073 | Liver Transpl | Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Implications for liver transplantation. | 2018 | Details |
| A14765 | 29249127 | Minerva Gastroenterol Dietol | Liver transplantation for non-alcoholic fatty liver disease. | 2017 | Details |
| A14799 | 29226105 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease: A Clinical Update. | 2017 | Details |
| A14813 | 29222911 | Hepatology | Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | 2018 | Details |
| A14829 | 29215462 | Transplantation | Liver Transplantation in Cryptogenic Cirrhosis: Outcome Comparisons Between NASH, Alcoholic, and AIH Cirrhosis. | 2018 | Details |
| A14994 | 29132522 | Prim Care | Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15011 | 29128058 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation. | 2017 | Details |
| A15018 | 29128051 | Clin Liver Dis | The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View. | 2018 | Details |
| A15026 | 29125712 | Liver Transpl | Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion. | 2018 | Details |
| A15042 | 29121675 | PLoS One | Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice. | 2017 | Details |